Gökçe Törüner
- Obstetrics and Gynecology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 11
- Genomic variations and chromosomal abnormalities 9
- Reproductive Medicine top 5%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 14
- Hematology top 10%
- Acute Myeloid Leukemia Research 22
- Chronic Myeloid Leukemia Treatments 13
-
- Lymphoma Diagnosis and Treatment 9
-
- Lung Cancer Treatments and Mutations 7
- Sarcoma Diagnosis and Treatment 6
- Co-authors
- Deanna StreckTayfun ÖzçelıkJames DermodyLee GengHarumi JyonouchiCemaliye Boylu AkyerliL. Jeffrey MedeirosGuilin Tang
- Partner nations
- United StatesTürkiyeChina
In The Last Decade
Gökçe Törüner
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Obstetrics and Gynecology 141
- Genetics 376
- Reproductive Medicine 108
- Cancer Research 192
- Hematology 140
Countries citing papers authored by Gökçe Törüner
This map shows the geographic impact of Gökçe Törüner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gökçe Törüner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gökçe Törüner more than expected).
Fields of papers citing papers by Gökçe Törüner
This network shows the impact of papers produced by Gökçe Törüner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gökçe Törüner. The network helps show where Gökçe Törüner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gökçe Törüner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 17 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 0 | |
| 12 | 2021 | 11 | |
| 13 | 2017 | 48 | |
| 14 | 2010 | 1 | |
| 15 | 2010 | 62 | |
| 16 | 2010 | 61 | |
| 17 | 2009 | 1 | |
| 18 | 2007 | 18 | |
| 19 | 2007 | 8 | |
| 20 | 2006 | 90 |
About Gökçe Törüner
Gökçe Törüner is a scholar working on Hematology, Genetics, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 86 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Cancer Genomics and Diagnostics (14 papers), Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Genomic variations and chromosomal abnormalities (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Obstetrics and Gynecology (141 citations), Genetics (376 citations), Reproductive Medicine (108 citations), Cancer Research (192 citations) and Hematology (140 citations). Gökçe Törüner has collaborated with scholars based in United States, Türkiye and China. Frequent co-authors include Deanna Streck, Tayfun Özçelık, James Dermody, Lee Geng, Harumi Jyonouchi, Cemaliye Boylu Akyerli, L. Jeffrey Medeiros, Guilin Tang, Mesut Tez and Zhenya Tang. Their work appears in journals such as Cancers, Modern Pathology, Genes, Human Pathology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.